Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis)
Overview
Plain-Language Overview
Trichomoniasis is a common sexually transmitted infection caused by the parasite Trichomonas vaginalis. It primarily affects the genital tract, including the vagina in women and the urethra in men. The infection often leads to symptoms such as vaginal itching, discharge, and discomfort during urination or intercourse. Many people, however, may have no symptoms at all, which can make it easy to unknowingly spread the infection. If untreated, it can cause complications like increased risk of other sexually transmitted infections and pregnancy problems. Diagnosis is usually made by testing samples from the affected areas.
Clinical Definition
Trichomoniasis is a sexually transmitted infection caused by the flagellated protozoan parasite Trichomonas vaginalis. It primarily involves the urogenital mucosa, causing vaginitis in women and urethritis in men. The parasite adheres to and damages epithelial cells, leading to inflammation characterized by vaginal discharge, pruritus, and dysuria. It is one of the most common non-viral STIs worldwide and is associated with increased susceptibility to HIV infection and adverse pregnancy outcomes. Diagnosis relies on identification of the organism in clinical specimens. The infection can be asymptomatic, especially in men, but remains a significant public health concern due to its transmissibility and complications.
Inciting Event
Sexual transmission through direct mucosal contact with infected secretions initiates infection.
Exposure to infected vaginal or urethral secretions during intercourse is the primary trigger.
Lack of barrier contraception facilitates protozoan transmission.
Latency Period
Symptoms typically develop within 5 to 28 days after exposure to Trichomonas vaginalis.
Asymptomatic colonization can persist for weeks to months before symptom onset.
Variable incubation period depending on host immune response and organism load.
Diagnostic Delay
Nonspecific symptoms such as vaginal discharge and pruritus are often attributed to bacterial vaginosis or yeast infection.
Asymptomatic infections in men and women lead to underdiagnosis and delayed treatment.
Lack of routine screening in asymptomatic individuals contributes to missed cases.
Microscopy sensitivity is limited, leading to false negatives if wet mount is performed improperly.
Clinical Presentation
Signs & Symptoms
Vaginal itching and burning sensation
Malodorous, frothy yellow-green vaginal discharge
Dysuria and urinary frequency in urethritis
Dyspareunia (painful intercourse)
Lower abdominal discomfort or pelvic pain in severe cases
History of Present Illness
Onset of malodorous, frothy yellow-green vaginal discharge often accompanied by vulvar itching and irritation.
Dysuria and urinary frequency may occur with urethral involvement.
Dyspareunia and vaginal discomfort are common complaints.
Symptoms may fluctuate in severity and worsen around menses.
Past Medical History
Previous sexually transmitted infections increase risk of reinfection and complications.
History of inconsistent condom use is relevant to exposure risk.
Prior episodes of bacterial vaginosis or candidiasis may coexist or be confused with trichomoniasis.
Family History
[]
Physical Exam Findings
Vaginal erythema and edema with a characteristic strawberry cervix appearance
Frothy, yellow-green vaginal discharge with a foul odor
Cervical petechiae visible on speculum examination
Urethral inflammation or discharge in males presenting with urethritis
Vulvar irritation and excoriations from scratching
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by detecting motile trichomonads on wet mount microscopy of vaginal or urethral discharge, which shows characteristic flagellated protozoa. The nucleic acid amplification test (NAAT) is the most sensitive and specific confirmatory test. Culture of Trichomonas vaginalis from clinical specimens is also diagnostic but less commonly used due to longer turnaround time. Clinical presentation with characteristic symptoms and positive laboratory identification confirms the diagnosis.
Pathophysiology
Key Mechanisms
Trophozoite adherence to vaginal and urethral epithelium causes local inflammation and tissue irritation.
Flagellated protozoan motility facilitates mucosal colonization and evasion of host defenses.
Release of proteolytic enzymes by Trichomonas vaginalis damages epithelial cells and disrupts mucosal barriers.
Neutrophilic infiltration leads to characteristic purulent discharge and mucosal erythema.
Altered vaginal microbiota and pH imbalance promote pathogen overgrowth and symptom development.
| Involvement | Details |
|---|---|
| Organs | Vagina is the primary organ affected, presenting with vaginitis symptoms such as discharge and pruritus. |
Urethra can be involved especially in males, causing urethritis and dysuria. | |
| Tissues | Vaginal mucosa is inflamed and damaged by Trichomonas vaginalis, leading to characteristic discharge and irritation. |
Urethral epithelium can be involved in male urethritis caused by Trichomonas vaginalis infection. | |
| Cells | Neutrophils mediate acute inflammation and contribute to vaginal discharge in trichomoniasis. |
Epithelial cells of the vaginal mucosa are the primary site of Trichomonas vaginalis adherence and damage. | |
| Chemical Mediators | Interleukin-8 (IL-8) is elevated in vaginal secretions, recruiting neutrophils and promoting inflammation. |
Tumor necrosis factor-alpha (TNF-α) contributes to local tissue inflammation and symptomatology. |
Treatments
Pharmacological Treatments
Metronidazole
- Mechanism:
Metronidazole causes DNA strand breakage and inhibits nucleic acid synthesis in Trichomonas vaginalis.
- Side effects:
Metallic taste
Nausea
Disulfiram-like reaction with alcohol
- Clinical role:
First-line
Tinidazole
- Mechanism:
Tinidazole disrupts DNA synthesis by causing strand breakage in Trichomonas vaginalis.
- Side effects:
Nausea
Headache
Disulfiram-like reaction with alcohol
- Clinical role:
First-line
Non-pharmacological Treatments
Abstinence from sexual intercourse until both partners complete treatment and symptoms resolve.
Partner notification and treatment to prevent reinfection and further transmission.
Prevention
Pharmacological Prevention
Metronidazole or tinidazole prophylaxis in high-risk populations is not routinely recommended but may be considered in recurrent cases
Treatment of sexual partners with oral metronidazole to prevent reinfection
No vaccine currently available for trichomoniasis prevention
Use of antimicrobial prophylaxis is limited to treatment rather than primary prevention
Avoidance of unnecessary antibiotic use to prevent resistance
Non-pharmacological Prevention
Consistent condom use to reduce transmission risk
Screening and treatment of sexual partners to prevent reinfection
Limiting number of sexual partners to decrease exposure risk
Regular STI screening in sexually active individuals
Education on genital hygiene and safe sexual practices
Outcome & Complications
Complications
Increased risk of HIV acquisition and transmission due to mucosal inflammation
Preterm labor and low birth weight in pregnant women
Pelvic inflammatory disease leading to infertility
Urethral stricture or chronic urethritis in males
Persistent or recurrent infection due to incomplete treatment or reinfection
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) versus Bacterial Vaginosis
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) | Bacterial Vaginosis |
|---|---|
Frothy, yellow-green vaginal discharge with a strong odor | Thin, grayish-white vaginal discharge with a fishy odor |
Motile, flagellated protozoa seen on wet mount | Clue cells (vaginal epithelial cells covered with bacteria) |
Vaginal pH >4.5 but often higher than in bacterial vaginosis | Vaginal pH >4.5 |
Responds to metronidazole or tinidazole | Responds to metronidazole or clindamycin |
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) versus Candida Vaginitis
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) | Candida Vaginitis |
|---|---|
Frothy, yellow-green vaginal discharge with a strong odor | Thick, white, curd-like vaginal discharge without strong odor |
Motile, flagellated protozoa on wet mount | Pseudohyphae and budding yeast on KOH prep |
Elevated vaginal pH (>4.5) | Normal vaginal pH (4.0–4.5) |
Pruritus present but often less intense | Severe vulvar itching and erythema |
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) versus Gonorrhea (Neisseria gonorrhoeae infection)
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) | Gonorrhea (Neisseria gonorrhoeae infection) |
|---|---|
Motile protozoan trophozoites on wet mount | Gram-negative diplococci on Gram stain |
Frothy, yellow-green vaginal discharge with flagellated organisms | Purulent, often yellow-green urethral or vaginal discharge |
Positive wet mount or NAAT for Trichomonas vaginalis | Positive nucleic acid amplification test (NAAT) for Neisseria gonorrhoeae |
Responds to metronidazole or tinidazole | Responds to ceftriaxone plus azithromycin |
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) versus Chlamydia trachomatis Infection
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) | Chlamydia trachomatis Infection |
|---|---|
Motile protozoan trophozoites on wet mount | Intracellular bacteria detected by NAAT |
Frothy, yellow-green vaginal discharge with strong odor | Mild mucopurulent discharge, often minimal symptoms |
Positive wet mount or NAAT for Trichomonas vaginalis | Positive NAAT for Chlamydia trachomatis |
Responds to metronidazole or tinidazole | Responds to azithromycin or doxycycline |
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) versus Herpes Simplex Virus (HSV) Infection
Trichomoniasis (Vaginitis, Urethritis - Trichomonas vaginalis) | Herpes Simplex Virus (HSV) Infection |
|---|---|
Frothy vaginal discharge without vesicles or ulcers | Painful vesicular or ulcerative genital lesions |
Positive wet mount or NAAT for Trichomonas vaginalis | Positive PCR or viral culture for HSV |
Usually localized symptoms without systemic illness | Systemic symptoms like fever and malaise during primary infection |